Keller G G - OmicsDI

Show results for

Unknown (1663)
Proteomics (165)
Transcriptomics (81)
Genomics (16)
Metabolomics (14)

Organisms

Andropogon gerardi (161)
Bacteria (161)
Bartonella quintana JK 31 (161)
Canis lupus familiaris (161)
Cnidaria (161)
Ensifer adhaerens (161)
Halictus scabiosae (161)
Human alphaherpesvirus 1 strain 17 (161)
Human alphaherpesvirus 1 strain KOS (161)
Human betaherpesvirus 5 (161)
Human herpesvirus 2 strain 186 (161)
Mesocricetus auratus (161)
Miscanthus x giganteus (161)
Homo sapiens (40)
Mus musculus (23)
Triticum aestivum (5)
Zea mays (4)
Solenopsis invicta (3)
Arabidopsis thaliana (3)
Schizosaccharomyces pombe (2)
Ovis aries (2)
Candida albicans (2)
Alexandrium fundyense (1)
Blumeria graminis (1)
Hordeum vulgare (1)
Bos taurus (1)
Caenorhabditis elegans (1)
Corynebacterium glutamicum ATCC 13032 (1)
Saccharomyces cerevisiae (1)
Drosophila melanogaster (1)

Organisms

Homo sapiens (1)

Repository

pride (161)
biostudies-arrayexpress (90)
MetaboLights (14)
EGA (6)
MassIVE (3)
ENA (2)

Tissue

Cell culture (29)
Epithelial cell (15)
Brain (10)
Early embryonic cell (8)
Skin (7)
HeLa cell (5)
Keratinocyte (5)
Liver (5)
Permanent cell line cell (5)
Kidney (4)
Blood (3)
Cell suspension culture (3)
T cell (3)
Blood cell (2)
Blood plasma (2)
Blood platelet (2)
Bone marrow (2)
Cytotoxic T-lymphocyte (2)
Embryo (2)
Heart (2)
Hepatocyte (2)
Kidney cell (2)
Macrophage (2)
Myocardium (2)
Neuron (2)
Plant cell (2)
Platelet (2)
Pollen (2)
Primary cell (2)
Skeletal muscle (2)

Disease

Wounds and Injuries (7)
Disease free (6)
Cervix carcinoma (3)
Acute leukemia (2)
Alzheimer's disease (2)
Colon cancer (2)
Basal cell carcinoma (1)
Breast cancer (1)
Chronic myeloid leukemia (1)
Cystinosis (1)
Drug dependence (1)
Epilepsy (1)
Fanconi anemia complementation group A (1)
Influenza (1)
Melanoma (1)
Multiple myeloma (1)
Myocardial ischemia (1)
Neuroblastoma (1)
Oral squamous cell carcinoma (1)
Ovarian cancer (1)
Pancreatic cancer (1)
Pancreatic ductal adenocarcinoma (1)
Platelet storage pool deficiency (1)
Septicemia (1)
Tuberculosis (1)
Type 2 diabetes mellitus (1)

Technology Type

Mass Spectrometry (161)
Shotgun proteomics (71)
Affinity purification coupled with mass spectrometry proteomics (27)
Bottom-up proteomics (20)
Data-dependent acquisition (18)
Gel-based experiment (15)
Mass spectrometry (12)
Data-independent acquisition (11)
SRM/MRM (8)
SWATH MS (8)
Chemical cross-linking coupled with mass spectrometry proteomics (6)
Top-down proteomics (5)
Mass spectrometry assay (2)
Illumina HiSeq 2000 (1)
All-ion fragmentation (1)
HDMSE (1)
Metaproteomics (1)

Instrument Platform

Liquid Chromatography MS - Positive (LC-MS (Positive)) (5)
Q Exactive (3)
Liquid Chromatography MS - negative - reverse phase (3)
Liquid Chromatography MS - positive - reverse phase (3)
Illumina NovaSeq 6000 (2)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (2)
Illumina Genome Analyzer IIx (1)
Illumina HiSeq 1500 (1)
Illumina HiSeq 4000 (1)
Orbitrap Exploris 480 (1)
LTQ Velos (Thermo Scientific) (1)
MALDI MS (Imaging MS) (1)
LMJ-SSP/ESI MS (Imaging MS) (1)
Liquid Chromatography MS (1)
Gas Chromatography MS - Positive (GC-MS (Positive)) (1)
Liquid Chromatography Tandem MS (LC-MS/MS) (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2023 (30)
2022 (22)
2021 (20)
2025 (20)
2024 (18)
2026 (18)
2020 (16)
2013 (16)
2019 (15)
2015 (15)
2016 (13)
2012 (11)
2014 (10)
2018 (10)
2011 (9)
2010 (9)
2005 (5)
2009 (4)
2017 (3)
2008 (3)
2007 (1)

CHEBI ID

CHEBI:15356 (2)
CHEBI:17126 (2)
CHEBI:22660 (2)
CHEBI:17234 (2)
CHEBI:28300 (2)
CHEBI:16244 (2)
CHEBI:25017 (2)
CHEBI:28044 (2)
CHEBI:116314 (2)
CHEBI:4047 (2)
CHEBI:28834 (2)
CHEBI:16359 (2)
CHEBI:29016 (2)
CHEBI:28484 (2)
CHEBI:17239 (2)
CHEBI:17750 (2)
CHEBI:18237 (2)
CHEBI:17858 (2)
CHEBI:16449 (2)
CHEBI:16737 (2)
CHEBI:15354 (2)
CHEBI:17368 (2)
CHEBI:30769 (2)
CHEBI:219654 (1)
CHEBI:80074 (1)
CHEBI:6820 (1)
CHEBI:181148 (1)
CHEBI:75970 (1)
CHEBI:15444 (1)
CHEBI:185794 (1)

Metabolite Name

TAG 59:12 (15:0/22:6/22:6) (2)
TAG 55:7 (15:0/18:1/22:6) (2)
TAG 55:6 (15:0/18:0/22:6) (2)
TAG 55:1 (15:0/18:1/22:0) (2)
TAG 51:5 (15:0/18:1/18:4) (2)
TAG 51:4 (15:0/18:1/18:3) (2)
TAG 51:3 (15:0/18:1/18:2) (2)
TAG 51:2 (15:0/18:1/18:1) (2)
TAG 49:1 (15:0/16:0/18:1) (2)
TAG 48:1 (14:0/16:0/18:1) (2)
TAG 48:1 (15:0/15:0/18:1) (2)
TAG 47:1 (14:0/15:0/18:1) (2)
O-Tyrosine (2)
Glucose (2)
Betaine (2)
Carnitine (2)
Choline (2)
Arginine (2)
Cytosine (2)
Alanine (2)
Phenylalanine (2)
Glutamine (2)
Cytidine (2)
Creatine (2)
Tetrocarcin A (1)
Akeboside Ste (1)
Lyso-PE 18:1 (1)
Lyso-PC 18:2 (1)
Disaccharide (Hex-Hex) (1)
Lyso-PE 16:0 (1)

First Public Date

2020 (1)
2017 (1)

Modification

N6-dimethyl-L-lysine (2)
-17.026549 (1)
-18.010565 (1)
15.994915 (1)
4-tetrahydrothiazine-3-carboxylic acid (1)
42.010565 (1)
4x(2)H labeled dimethylated L-lysine (1)
57.021464 (1)

Study type

Transcription profiling by array (51)
RNA-seq of coding RNA (19)
ChIP-seq (8)
Other (3)
RNA-seq of non coding RNA (3)
Unknown experiment type (1)
Transcription profiling by tiling array (1)
CLIP-seq (1)
Transcription profiling by RT-PCR (1)
Methylation profiling by array (1)
Proteomic profiling by array (1)

Release Date

2021 (191)
2022 (175)
2025 (155)
2023 (147)
2024 (143)
2020 (131)
2015 (94)
2019 (92)
2018 (92)
2017 (85)
2014 (75)
2016 (74)
2013 (61)
2012 (47)
2011 (39)
2010 (34)
2026 (31)
2009 (23)
2008 (14)
2005 (12)
2006 (10)
2007 (9)
2004 (5)
2003 (4)
2002 (4)
2001 (3)
1998 (2)
2000 (1)

Lab affiliation

Bioplatforms Australia (7)
ETHZ IMSB (4)
Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland (4)
Novartis Inst. for BioMedical Research (4)
IBCII, Goethe University Frankfurt, Germany, Medical School (3)
Institute of Biochemistry (3)
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria (2)
Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, 66421 Homburg, Germany (2)
Department of Biology, Institute of Microbiology, ETH Zürich, Switzerland (2)
Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland (2)
Department of Biotechnology and Biomedicine, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark (2)
Eppley Institute for Research in Cancer University of Nebraska Medical Center Omaha, NE 68198, USA (2)
Institute for Microbiology, University of Greifswald, Felix-Hausdorff-Straße 8, 17489 Greifswald, Germany (2)
LEO Foundation Center for Cutaneous Drug Delivery Department of Pharmacy University of Copenhagen Denmark (2)
Queensland Brain Institute, The University of Queensland, St Lucia Campus (Brisbane), QLD 4072, Australia (2)
Section for Protein Science and Biotherapeutics, Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads, 2800, Kongens Lyngby, Denmark (2)
The University of Melbourne (2)
The University of Sydney (2)
Ackermannweg 4, 55128 Mainz, Germany (1)
Associate Professor Department of Clinical and Molecular Medicine Faculty of Medicine and Health Sciences +47 72824684 Laboratoriesenteret, Øya (1)
Balwant S. Tuana Professor | Director, CMM Graduate Program University of Ottawa, Room#3206 451 Smyth Road, K1H 8M5, Ottawa, Ontario, Canada (1)
Biological Sciences, University of Southampton (1)
Bioplatforms Australia (project manager) (1)
Biotech Research & Innovation Center (BRIC), University of Copenhagen, Denmark (1)
CCMAR (Center of Marine Sciences), Universidade do Algarve,Campus de Gambelas, Portugal (1)
CCMAR (Center of Marine Sciences, Universidade do Algarve,Campus de Gambelas, Portugal (1)
CIIMAR Terminal de Cruzeiros do Porto de Leixões Avenida General Norton de Matos, S/N 4450-208 Matosinhos | Portugal (1)
CNIC (1)
CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, CIIL – Centre d’Infection et d’Immunité de Lille, Univ. Lille, 59000 Lille, France (1)
CRUK -CRUK Scotland nstitute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (1)

Previous page
1 / 194
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 194
Next page

Sort by:

Relevance

Page size

Global survey of canonical Aspergillus flavus G protein-coupled receptors.

Not available

S-EPMC4205791 | biostudies-literature

Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation.

Not available

S-EPMC8748714 | biostudies-literature

MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF.

Not available

S-EPMC8630008 | biostudies-literature

G protein-coupled receptors function as logic gates for nanoparticle binding and cell uptake.

Not available

S-EPMC2890824 | biostudies-literature

Topoisomerase 1 inhibits MYC promoter activity by inducing G-quadruplex formation.

Not available

S-EPMC9226537 | biostudies-literature

Phospholipid acyl chain diversity controls the tissue-specific assembly of mitochondrial cardiolipins

Cardiolipin (CL) is a phospholipid specific for mitochondrial membranes and crucial for many core tasks of this organelle. Its side chain configurations are tissue-specific, functionally important and generated via post-biosynthetic remodeling. However, this process lacks the necessary specificit...

2020-05-22 | MTBLS1446 | MetaboLights

Genome-wide profiling of miRNA expression dynamics in monocyte-derived dendritic cells following infection with a panel of intra-cellular bacteria

We report the application of RNA sequencing to assess the expression dynamics of miRNAs and their isoforms over time upon infection with a panel of six intracellular bacteria (Mycobacterium tuberculosis H37Rv, Mycobacterium tuberculosis Beijing strain GC1237, Mycobacterium bovis BCG, Salmonella typh...

ORGANISM(S): Homo sapiens

2015-02-18 | E-GEOD-64142 | biostudies-arrayexpress

Loss of the mammalian G-protein coupled receptor, G2A, modulates severity of invasive pulmonary aspergillosis.

Not available

S-EPMC10331294 | biostudies-literature

Cost-Efficiency and Cost-Effectiveness of Alternative Bouillon Fortification Programs: Evidence for Burkina Faso, Nigeria, and Senegal.

Not available

S-EPMC12917931 | biostudies-literature

The systematic shortening of 3’ UTRs has limited influence on the relative change in protein abundance in proliferating cells

Alternative polyadenylation is an important cellular mechanism that enables generation of mRNA isoforms that differ in their 3' untranslated regions (3' UTRs) and consequently in their susceptibility to miRNA and RNA binding protein mediated regulation. A dramatic change in polyadenylation site usa...

ORGANISM(S): Homo sapiens

2014-09-25 | E-GEOD-54950 | biostudies-arrayexpress

Previous page
1 / 194
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 194
Next page

Sort by:

Relevance

Page size

1939 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Modification

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets